Oseltamivir prophylaxis during the influenza season in a paediatric cancer centre: Prospective observational study

Hong Kong Medical Journal

Volumn 10, Issue 2, 2004, Pages 103-106

  Chik, K W ^a   Li, C K ^a   Chan, P K S ^a   Shing, M M K ^a   Lee, V ^a   Tam, J S L ^a   Yuen, P M P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Acetamides; Antiviral agents; Influenza; Neuraminidase antagonists inhibitors

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; OSELTAMIVIR; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; BONE MARROW TRANSPLANTATION; CANCER; CANCER CENTER; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG MEGADOSE; EPIDEMIC; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HEMATOLOGIC DISEASE; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MALE; NAUSEA; PATIENT COMPLIANCE; PROPHYLAXIS; SEROLOGY; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION; VIROLOGY; VIRUS CULTURE; VOMITING;

ACETAMIDES; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HOSPITALS, PEDIATRIC; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFLUENZA, HUMAN; MALE; NEOPLASMS; ONCOLOGY SERVICE, HOSPITAL; OSELTAMIVIR; PROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 1842663228     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kempe A, Hall CB, MacDonald NE, et al. Influenza in children with cancer. J Pediatr 1989;115:33-9.
2. American Academy of Pediatrics. Influenza. In: Pickering LK, editor. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2000:351-9.
3. Lujan-Zilbermann J, Benaim E, Tong X, Srivastava DK, Patrick CC, DeVincenzo JP. Respiratory virus infections in pediatric hematopoietic stem cell transplantation. Clin Infect Dis 2001;33:962-8.
4. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001;20:127-33.
5. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000;355:1845-50.
6. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000;283:1016-24.
7. Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Eng J Med 1999;341:1336-43.
8. Welliver R, Monto AS, Carewicz O, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001;285:748-54.
9. Peters PH Jr, Gravenstein S, Norwood P, et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001;49:1025-31.
10. Influenza surveillance: consultation rate of influenza-like illness and number of influenza isolates, 2001. Hong Kong Department of Health website: http://www.info.gov.hk/dh/diseases/flu_chart2001.htm. Accessed 17 June 2003.
11. Feldman S, Webster RG, Sugg M. Influenza in children and young adults with cancer: 20 cases. Cancer 1977;39:350-3.
12. Chisholm JC, Devine T, Charlett A, Pinkerton CR, Zambon M. Response to influenza immunisation during treatment for cancer. Arch Dis Child 2001;84:496-500.
13. Poehling KA, Edwards KM. Prevention, diagnosis, and treatment of influenza: current and future options. Curr Opin Pediatr 2001;13:60-4.
14. Fitzner KA, Shortridge KF, McGhee SM, Hedley AJ. Cost-effectiveness study on influenza prevention in Hong Kong. Health Policy 2001;56:215-34.